Trial intelligence / Profile preview

Kezimuke granules vs levofloxacin for acute uncomplicated lower urinary tract infection

CTR20250480Phase 3Active

Sponsor
Altay Prefecture Kazakh Medicine Hospital
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Kezimuke Keli in bacterial cystitis, urinary tract infection (UTI), cystitis, sponsored by Altay Prefecture Kazakh Medicine Hospital. Started Mar 2025; status: active.

02

Drugs

Kezimuke Keli
03

Conditions

bacterial cystitisurinary tract infection (UTI)cystitis

Beyond the preview

Go deeper on CTR20250480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20250480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call